Genetic Testing for Hereditary Breast/Ovarian Cancer(BRCA1/2)

• 

According to research reports, individuals with inherited cancer genes have a higher risk of cancer than ordinary people. About 7% of breast cancer and 1%-15% of ovarian cancer are caused by brca1 and brca2 genesmutations. In families with a high incidence of breast and ovarian cancer, 80% of patients have mutations in the BRCA1/BRCA2 gene, and this gene is inherited in an autosomal dominant manner in the population.

This test detects the entire coding region of BRCA1/BRCA2 genes, and 20bp intron regions upstream and downstream of the coding region, in addition to known mutation hotspot genes, unknown mutations can be detected.

Clinical applications:

Preventive guidance - Detection of brca1 and brca2 testinggene mutations can provide references for disease risk assessment to high-risk groups or healthy people, reduce the risk of disease through preventive treatment, and provide references for disease risk assessment to relatives of mutation carriers.

Medication guidance - Breast cancer and ovarian cancer patients with BRCA1/BRCA2 mutations are more sensitive to platinum and PARP inhibitor drugs (Olaparib), A large proportion of patients with BRCA1/ BRCA2 gene mutations are triple-negative breast cancers, which are more sensitive to platinum-based chemotherapy.

Prognostic assessment - BRCA1/BRCA2 gene mutation carriers have a relatively high risk of ipsilateral breast recurrence or contralateral breast cancer. BRCA1/BRCA2 gene mutations are relative contraindication to breast-conserving therapy.

For more information about breast cancer brcaand in vitro diagnostics, please feel free to contact us!

There are many rna sequencing companies, but we are one of the best choices for you.

Другие товары поставщика

	Pediatric Pharmacogenomics Detection	The problem of drug safety for newborns and children is very serious. According to data from the Adverse Drug Reaction Monitoring Center of the Min...
	Individualized Medication Guidance for Breast Cancer	This test detects 348 genes, including HRR pathway genes. The content involves targeted breast cancer therapy, immunotherapy, chemotherapy and here...
	CNV-seq Detection (Semiconductor Sequencing)	The detection kit, which is based on the BES 4000 platform, is used to perform low-depth whole-genome sequencing of DNA. The sequencing results are...
	CapitalBio® Microarray Scanner LuxScan™10K/D	CapitalBio® Microarray Scanner LuxScan™10K/D, a novel optical system design based on the laser confocal principle, improves detection sen...
	CMA Detection	The CMA testof CapitalBio Technology uses Affymetrix GeneChip System 3000Dx and CytoScan 750K chip, it can not only provide accurate detection of c...

Похожие товары

	Shecare HCG Pregnancy Rapid Test Dipstick Strips	Продавец: Shecare-ikangtai	Smart HCG Test Strips The working principle of pregnancy test using hcg urine test dipstickis to...
	Shecare Fetal Heart Beat Monitor	Продавец: Shecare-ikangtai	Fetal Heart Beat Monitor Apply appropriate coupling agent, slowly move the baby heartbeat with p...
	Shecare Digital Thermometer Manufacturer	Продавец: Shecare-ikangtai	Digital Thermometer 【Accurate & Fast Reading】 The Shecare Digital Oral Thermometer, Switchab...
	Shecare COVID-19 IgG/IgM Test Kit	Продавец: Shecare-ikangtai	COVID-19 IgG/IgM Test Kit COVID 19 test kit(Whole Blood/Serum/Plasma) is a solid phase immunochr...
	Shecare Smart Test Strip Recognition SaaS SDK	Продавец: Shecare-ikangtai	Based on millions of user data, the ‘Attention’ mechanism & ‘Deep Learning ...